Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
MedTech
Roche nabs European approval for second Alzheimer’s test
Roche has secured a European CE mark for its second Alzheimer’s test that can both help confirm the disease and rule it out.
Ben Adams
May 12, 2026 7:07am
Roche shells out up to $1B for PathAI to boost AI diagnostics
May 7, 2026 9:30am
Fierce Pharma
Roche exec: Giredestrant may become company’s largest product
Apr 23, 2026 2:52pm
Roche CEO gives 3 reasons for sitting out Big Pharma M&A spree
Apr 23, 2026 5:18am
Roche unpacks death imbalance in multiple sclerosis ph. 3 trials
Apr 21, 2026 7:15pm
Foundation Medicine expands BMS collab with new diagnostic target
Apr 21, 2026 7:16am
